Found 137 articles for: "COVID"
Recognizing and Advancing Leadership in Dermatology: Promoting the Health Care Administration, Leadership, and Management Subspecialty
December 2024 | Volume 23 | Issue 12 | Features | e191 | Copyright © December 2024
The recognition and development of leadership training within dermatology has taken on new importance in recent years. In Spring 2023, the American Board of Medical Specialties announced the laun...
Read MoreLight and Laser-Imaging Detection and Ranging (LiDAR) in Dermatology: A New Dimension for Digital Healthcare
December 2024 | Volume 23 | Issue 12 | Editorials | e197 | Copyright © December 2024
Algorithmic Beauty: The New Beauty Standard
September 2024 | Volume 23 | Issue 9 | Original Article | 742 | Copyright © September 2024
Background: Algorithms on various social media platforms feed users what it considers "beautiful", impacting the aesthetic desires of patients as well as beauty ideals.Tildrakizumab Real-World Effectiveness and Safety Over 64 Weeks in Patients With Moderate-to-Severe Plaque Psoriasis
August 2024 | Volume 23 | Issue 8 | Original Article | 612 | Copyright © August 2024
Background: Tildrakizumab is a humanized anti-interleukin-23 p19 monoclonal antibody approved for the treatment of moderate-to-severe plaque psoriasis. This report describes real-world effectiveness a...
Read MoreEfficacy and Safety of Secukinumab in the Treatment of Psoriasis in Patients with Skin Phototypes IV to VI
August 2024 | Volume 23 | Issue 8 | Original Article | 600 | Copyright © August 2024
Background: There is a paucity of data on the treatment of psoriasis in patients with skin of color – a diverse population among whom variations in clinical features and hi...
Read MoreReal-life Effectiveness and Safety of Guselkumab in Moderate-to-Severe Plaque Psoriasis: A 104-Week Retrospective Single-Center Study
August 2024 | Volume 23 | Issue 8 | Original Article | 632 | Copyright © August 2024
Background: Guselkumab is a monoclonal antibody approved for treating moderate-to-severe plaque psoriasis. Long-term data on the effectiveness and safety of guselkumab in a real-...
Read MoreA Prospective, Multicenter, Evaluator-Blinded, Randomized Study of Diluted Calcium Hydroxylapatite to Treat Decollete Wrinkles
July 2024 | Volume 23 | Issue 7 | Original Article | 551 | Copyright © July 2024
Background: Calcium hydroxylapatite (CaHA) dermal filler is used for a variety of aesthetic treatments; however, the safety and effectiveness of diluted CaHA for the treatment of...
Read MoreDermTok: Who's Talking Sun? A Cross-Sectional Analysis of Sun Protection Content on TikTok
July 2024 | Volume 23 | Issue 7 | Features | 571 | Copyright © July 2024
Despite the widespread interest in dermatology on TikTok, studies have shown most related videos are not produced by board-certified dermatologists (BCDs) or other health professionals. To see if this...
Read MoreAn Open-label Study to Investigate the Efficacy and Tolerability of Dapsone Gel, 7.5% in the Treatment of Acne Vulgaris in Men and Women With Skin of Color
June 2024 | Volume 23 | Issue 6 | Original Article | 410 | Copyright © June 2024
Introduction: Acne vulgaris is a common skin disease prevalent in skin of color patients. Studies have demonstrated that dapsone gel, 7.5% (Aczone) used once daily is effective, ...
Read MoreEfficacy and Safety of Micronized Isotretinoin Administered Once Daily Without Food in Patients With Recalcitrant Nodular Acne
June 2024 | Volume 23 | Issue 6 | Original Article | 423 | Copyright © June 2024
Introduction: Micronized isotretinoin 0.4 to 0.8 mg/kg/day administered in 2 divided doses with or without meals is approved for the treatment of severe nodular acne in patients ...
Read MorePhotodynamic Skincare: A Prospective Single-Center Study
May 2024 | Volume 23 | Issue 5 | Original Article | 332 | Copyright © May 2024
Background: Peer-reviewed, clinical studies measuring the efficacy and usability of skin care products enhance their integrity and may guide experts in the field in providing rec...
Read MoreThe National Mentorship Match Algorithm: Mentors Needed
May 2024 | Volume 23 | Issue 5 | Editorials | e127 | Copyright © May 2024
Read MoreHidradenitis Suppurativa Found Associated With Cytokine Storm
May 2024 | Volume 23 | Issue 5 | Editorials | e134 | Copyright © May 2024
Background: Hidradenitis suppurativa (HS) is a chronic inflammatory disease that generates multiple cytokines. Here, we present an example of the cytokines forming a cytokine sto...
Read MoreA Pearl for Pretibial and Forearm Repair Following Mohs Micrographic Surgery
May 2024 | Volume 23 | Issue 5 | Case Reports | 380 | Copyright © May 2024
Wound repair of the pretibial and forearm regions presents a challenge during dermatologic surgery as these areas are under significant tension and exhibit increased skin fragility. Various metho...
Read MoreHydroxychloroquine-Induced Nonthrombocytopenic Purpura: A Case Series
May 2024 | Volume 23 | Issue 5 | Case Reports | e124 | Copyright © May 2024
Hydroxychloroquine (HCQ) is a disease-modifying anti-rheumatic medication for the treatment of various autoimmune conditions. A rare side effect of HCQ is thrombotic thrombocytopenic purpura (TTP). We...
Read MoreCOVID-19 Protection Strategies: Lessons Learned About Epidermal Barrier Function and the Significance of Optimized Skin Care
April 2024 | Volume 23 | Issue 4 | Original Article | 244 | Copyright © April 2024
Initially categorized as primarily a respiratory disease, COVID-19 can involve other organ systems and may have direct skin manifestations, including exanthems, morbilliform eruption, generalized...
Read MoreComparing the Safety and Effectiveness of Microfocused Ultrasound: Standard vs Targeted Tissue Protocol in Lifting and Tightening the Lower Face and Upper Neck
April 2024 | Volume 23 | Issue 4 | Original Article | 249 | Copyright © April 2024
Background: Micro-focused ultrasound with visualization (MFU-V) delivers energy to specific soft tissue layers beneath the epidermis with the ability to lift and tighten the lowe...
Read MoreA Novel Systems-Wide Approach in Addressing Acne with a Multi-Targeting Nutraceutical
March 2024 | Volume 23 | Issue 3 | Original Article | 160 | Copyright © March 2024
Acne vulgaris (AV) is one of the top concerns dermatologists encounter from women. Until now, therapies addressing AV have largely centered around, and have been successful at, targeting the path...
Read MoreComplementary and Alternative Medicine for Hidradenitis Suppurativa Discussed on TikTok: A Cross-Sectional Analysis
March 2024 | Volume 23 | Issue 3 | Editorials | e93 | Copyright © March 2024
Background: Hidradenitis suppurativa (HS) is a painful, chronic inflammatory skin disease that negatively affects patient quality of life, and conventional treatments are variabl...
Read MoreHalobetasol Propionate 0.01% and Tazarotene 0.045% Lotion With a Ceramide-Containing Moisturizer in Adults With Psoriasis
February 2024 | Volume 23 | Issue 2 | Original Article | 50 | Copyright © February 2024
Media and other results for: "COVID"
© 2023 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.
